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 Optical coherence tomography(OCT) is an in vivo non-invasive biomedical imaging modality capable 
of detecting BCCs in vivo and ex vivo. 
 OCT can detect BCCs in ex vivo MMS skin samples from different anatomical regions.  
 OCT can differentiate between different BCC subtypes.  
 OCT could provide a potential role in reducing the number of stages required in Mohs micrographic 




Background: Mohs micrographic surgery (MMS) is an effective treatment for certain non-melanoma skin cancers. Optical 
coherence tomography (OCT) is a biomedical imaging modality that permits high-resolution imaging of the epidermis and 
dermis with the potential to detect both healthy tissue and tumour. OCT may also provide a means of detecting and 
differentiating between the various histological subtypes of basal cell carcinomas (BCC) in vivo. 
 
Objective: The aim of this prospective ex vivo study was to evaluate the efficacy of OCT in recognising healthy and 
pathological margins of excised BCC lesions and detecting different BCC subtypes. 
Methods: Seventy-three subjects with biopsy-proven BCCs on the facial region undergoing MMS were recruited. Narrow 
clinically healthy margins of the skin surrounding the tumour were included in the excisional biopsy. Biopsies were scanned 
with the OCT instrument immediately ex vivo and processed to obtain horizontal Mohs frozen sections and compared with 
their corresponding OCT images.  
Results: Histopathological analysis of 280 margins showed 232 tumour free margins and 48 tumour-involved margins.  OCT 
showed very good sensitivity (81.2%) and specificity (94.3%) in detecting healthy from tumour-involved margins. OCT 
accuracy was 93.4%, and the intra- and inter-observer reliability was substantial (Kappa value ranged between 0.63-0.76). 
Conclusion: This study shows the accuracy of ex vivo OCT in identifying the margin status of BCCs of the head and neck 
region. Moreover, this modality has demonstrated good capability in distinguishing different BCC subtypes and the potential 




       BCC is the most common non-melanoma skin cancer globally, with an incidence that continues to 
increase year-on-year [1-3]. Mohs micrographic surgery (MMS) is a precise method in which skin cancers 
such as BCCs are surgically removed under microscopic margin control [4]. It allows complete margin 
control during skin cancer removal (CCPDMA – complete circumferential peripheral and deep margin 
assessment), using horizontal frozen section histology [5,6]. MMS facilitates extirpation of skin cancers 
with high cure rate and a narrow surgical margin [7,8]. The cure rate with MMS cited by most studies 
ranges from 97% to 99.8% for primary BCC and 94% for recurrent BCC [9]. However, MMS is generally 
more time-consuming and labour-intensive than traditional surgery due to the processing of frozen 
haematoxylin–eosin (H&E) sections.  
       Accordingly, the combination of MMS with a non-invasive and in real-time modality, such as 
confocal laser scanning microscopy or OCT, may expedite and facilitate the evaluation of cancer tissue 
margins as soon as the excision has been performed. The OCT technique has been previously utilised ex 
vivo for the recognition of BCC prior to Mohs horizontal frozen sectioning of excised tissue and showed a 
low sensitivity (19%) and specificity (56%) [10]. In another recent study, a new high-definition optical 
coherence tomography (HD-OCT) device (Skintell, AgfaHealthCare, Belgium) utilised 20 excisional 
biopsies of BCCs to evaluate the feasibility of ex vivo HD-OCT in analysing tumour margins compared 
with the gold standard H&E [11]. The authors reported a higher sensitivity (74%) and specificity (64%) 
compared with Cunha et al. study [10]. 
        The objective of this prospective clinical ex vivo study was to examine the accuracy of the OCT 
instrument against Mohs frozen section histology in recognising the healthy and tumour-laden margins of 
excised BCC lesions in the facial region. The ability of OCT in distinguishing various BCC subtypes was 
also assessed.   
 
2. Patients and methods 
 
2.1. Patients 
        
       Seventy-three subjects with biopsy-proven BCC undergoing MMS at University College London 
Hospitals Dermatology Department were selected and recruited for the current study. Inclusion criteria 
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included patients above 18 years old. Additional inclusion criteria were clinically apparent lesions that had 
not undergone any previous treatment modality including topical therapeutic agents such as imiquimod, 5-
fluorouracil or photodynamic therapy. The study protocol was approved by the NRES (national research 






2.2. Methods/study designs 
        
       Subjects with biopsy-proven BCCs on the facial region referred for MMS were prepared by mapping 
the boundary of the lesion with the naked eye using a surgical skin marker pen. A 1-2mm margin of 
clinically apparent healthy skin around the tumour was included in the Mohs extirpation. Following the 
first and possible further stages of MMS, the OCT instrument was used for immediate ex vivo scanning 
and capturing images of the margins of the specimen to verify its status. Specimens were placed on a piece 
of gauze with the epidermis facing upwards, and subsequently onto a Petri dish. Four margins per biopsy 
tissue were studied (total number 292). The four locations scanned were at the 3, 6, 9, and 12 o’clock 
positions. Scanning was initiated from the periphery towards the centre for each location (Fig. 1). For 
biopsies larger than 6mm in diameter, each margin was scanned several times to cover all areas from 
periphery towards the centre using assembled composite images. As part of our routine practice the 
biopsies were then processed for horizontal frozen sections by a Mohs histotechnician after image 
acquisition of the specimen using the OCT instrument. The acquired OCT images of the specimen margins 
were then compared with their corresponding H&E sections. 
 
       Two investigators (D.R. & C.H.) independently examined and compared the OCT images with the 
H&E slides to ascertain whether the margins were clear or involved. The margin status of the Mohs 
sections was determined by a Consultant Mohs surgeon (C.P.) and a Consultant Histopathologist (A.F.). 
Assessment was conducted according to WHO guidelines. The criteria employed to identify and rate a 
margin as negative (tumour-free) were the presence of an intact dermo-epidermal junction (DEJ) with 
normal overlying epidermis layer and underlying dermis layer (Fig. 2), whereas for identification of a BCC 
in the positive margin (tumour-laden margin), at least one of the following criteria was required: presence 
of honeycomb-like aggregates (lobules of small tumour), dark rounded areas (islands of tumour nests), or 
plug-like signal-intense structures (dense tumour clusters) with or without breached DEJ (Fig. 3). The two 
assessors re-examined all the OCT images after 5 weeks to determine intra-observer differences, whereas 
inter-observer agreement was obtained by comparing the assessors’ findings. 
 
2.3. Optical coherence tomography oral instrument 
 
       In this study, we used a recent variant (OCT oral instrument, version 2.1) of a commercial frequency 
domain swept source OCT dermatological instrument (SS-OCT, VivoSight® Michelson Diagnostics Ltd, 
version 2.0, Orpington, Kent, UK). The OCT oral instrument features an extended optical path relaying the 
imaging aperture into the oral cavity and imaging through a final right angle mirror, for improved intra-
oral soft and hard tissue imaging accessibility (Fig. 4). 
       The light source utilised by this instrument is Santec HSL-2000 swept laser with a centre wavelength 
of 1305± 15nm, and sweep range of 150nm. VivoSight® utilises four staggered OCT sources and is ideally 
suited to applications in scattering media such as skin and tumour tissue. In standard configuration, the 
instrument is reported to achieve axial and lateral resolutions of < 10μm over a depth range of 2mm and 
image width up to 6mm [12]. The tissue penetration depth is around 1-2mm depending on the optical 
absorption and scattering properties of the tissue being imaged [12]. In addition, the system can generate 





2.4. Statistical analysis 
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       The effectiveness, sensitivity, specificity and overall accuracy of OCT (not accounting for chance 
agreement) were calculated in Excel, Microsoft Office 2003 according to the data provided by both 
investigators. Kappa statistics were calculated in ‘2015 GraphPad Prism Software’ to assess the agreement 
between the readers and interpreted as poor if κ < 0.00, slight if 0.00 ≤ κ ≤ to 0.20, fair if 0.21 ≤ κ ≤ to 
0.40, moderate if 0.41 ≤ κ ≤ to 0.60, substantial if 0.61 ≤ κ ≤ 0.80, almost perfect (or excellent) if κ > 0.80 






       The mean age of patients was 67.5 years (range 26–96). There were 39 male and 34 female subjects. 
BCC lesions were mainly of mixed subtypes (two or more than two subtypes) in 27 cases, followed by 
nodular (20), micronodular (11), infiltrative (8) and superficial subtype (7) (Figs. 7-9). Cheek (17) and 
nose (17) were the commonest locations for the BCC lesions, followed by forehead/temple (14), periorbital 
area (10) and scalp (10), whilst ears (3) and lips (2) were the least common locations (Table 1). 
       Histopathological analysis of 292 margins showed 232 tumour free margins and 48 tumour-involved 
margins. Twelve margins were excluded because of distortion (severe artefact) during histopathologic 
processing and poor quality OCT images.  
  
       The intra-observer agreement was substantial (Kappa statistic= 0.76). Furthermore, the degree of 
concordance between both readers (inter-observer agreement) was also substantial, although the kappa 
statistic was a little lower (Kappa statistic= 0.63). 
 
4. Discussion 
        
       The results of this study demonstrated that epidermis, dermis (papillary and reticular layers) and DEJ 
can be clearly identified with OCT. The loss of normal characteristic skin layers seen in BCCs can be 
detected on OCT images. 
       The OCT penetration depth in the current study was limited to a maximum of only 1-1.5mm, which is 
adequate to visualise both the epidermis and dermis layers where most of the pathological changes are 
seen. However, BCCs and nests that penetrate deeper (2mm onwards) in the lower reticular dermis or 
subcutaneous layers are beyond the scope of OCT, reflecting its relatively shallow penetration depth 
ability. The lateral and axial resolution of 10-15μm would not permit single cell detection. Nevertheless, 
one of the advantages of OCT over confocal laser scanning microscopy (CLSM), which has non-
invasively achieved 1μm resolution with a 200-400μm field of view in near real time, albeit with a shallow 
penetration depth of up to 500μm [14-19], is the possibility of microanatomical structure analysis to a 
depth of 1500μm. On this basis, identification of abnormalities that extend from the papillary dermis to the 
upper reticular dermis seems possible. This involves regions where the epidermis has slight thickness, in 
which assessment of part of the reticular epidermis can be achieved [20,21].  
       In the current study, OCT images of nodular and micronodular BCC subtypes where characterised by 
distinctive circular or oval tumour aggregate formation in the epidermal and upper dermal layers. While 
the infiltrative subtype OCT images showed tumour nests much smaller in width (the majority were two 
cells in width), with jagged contours giving the appearance of either straight or curved small spikes and 
strands of tissue. The superficial BCC growth pattern in the OCT images appeared as an atypical basaloid 
proliferation parallel to the long axis of the epidermal layer and showed little or no penetration into the 
dermal layer. The OCT instrument may in the future, with further refinement, prove useful in 
differentiating the different BCC subtypes. 
       In this study BCCs showed characteristic features on examination with the OCT instrument, although 
some OCT images were difficult to interpret due to lack of sufficient contrast (image quality) and 
resolution. In such instances it was challenging to define the borders of the nests and strands of the BCC 
subtypes and differentiate them from the adnexal structures (particularly sebaceous glands), and shadow 
artefacts resulting from hyperreflectivity of the keratinised or ulcerated outer surface layers of the skin. In 
concordance with Cunha et al. study [10], previously described OCT features of BCC including 
honeycomb-like signal-free structures, large plug-like signal-intense structures and prominent signal-free 
cavities in upper dermis [22] were not identified in our study. However, adnexal structures were identified, 
although often difficult to differentiate from tumour in some specimens.  
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       Another prospective study which used in vivo OCT to examine 43 BCCs, reported the capability of in 
vivo OCT in imaging the altered architecture of skin layers and histological correlates of BCC. The BCC 
tumour nests in its different shapes, i.e. lobules, islands, and infiltrating strands appeared similar in OCT 
images and histopathology pictures, regardless of the tumour subtype [22]. Our study showed similar 
results with regard to detection of disorder in skin layer architecture in the presence of BCC but at the 
same time recognised dissimilar BCC nests, although our clinical study was ex vivo in nature and utilised a 
different OCT system. 
 
        OCT sensitivity and specificity compared with Mohs histopathology for distinguishing BCC margins 
were 81.2% and 94.3% respectively. The positive predictive value was 80.5% and the negative predictive 
value was 96.1%. Prevalence was 0.16, OCT accuracy was 93.3% and the Kappa statistic was 0.76 (95% 
confidence interval (CI): from 0.65 to 0.87) (substantial agreement). Positive likelihood ratio (LR+) was 
22 and negative likelihood ratio (LR-) was 0.24, suggesting that OCT instrument is useful and provides 
evidence to support our hypothesis. However, the investigators encountered difficulties in interpreting 
some of the tumour margins, either due to OCT limited penetration depth or appearance of dark 
(hyporeflective) structures, which resulted in some false positives and negatives, respectively (Figs. 5 and 
6).   
 
       In our study, identification of cutaneous tumour resection margins with OCT was demonstrated. 
Utilising any optical non-invasive diagnostic method in order to improve the accuracy of excisions might 
confer an advantage to patients by preserving as much normal tissue as possible, particularly in the head 
and neck region where function and cosmesis are of important as well as reducing the number of surgeries. 
However, the current OCT instrument technology needs refining (by improving image resolution and 
penetration depth) in order to optimise its use in the clinical setting and obtain trustworthy data especially 
for lesions penetrating deeper into the tissue (exceeding 2mm). 
       Facial cutaneous malignancies can extend below the surface, and indeed more so than clinical 
examination might suggest. Such lesions may also have indistinct clinical margins, requiring several stages 
of Mohs surgery to achieve complete clearance. In a recent study, a laboratory bench-top OCT microscope 
with similar 4 beam construction and resolution (EX1301; Michelson Diagnostics, Orpington, Kent, UK) 
was compared with conventional frozen-section histopathology for visualising BCC during MMS. In a 
study of 38 patients, the authors noted that on the average, the mean time to produce one OCT image was 7 
minutes, whereas 20-40 minutes were required to produce H&E sections [10]. However, our hand-held 
oral probe OCT system was faster in comparison, with an image acquisition times of approximately 15-30 
seconds per margin, i.e. 2 minutes per lesion if four locations were scanned. Therefore, the real-time 
intraoperative OCT system is unlikely to lengthen the time of the surgical procedure and will provide near-
instantaneous imaging feedback to the operator.  
       It is unlikely that intraoperative OCT imaging will identify occult deeper tumour areas, as presently 
the greatest depth of penetration of OCT imaging is around 2mm. Therefore, in iceberg-shaped tumours 
for instance, resection margin analysis would be difficult. The majority of false negative readings in the 
current study were related to this phenomenon.  
       Notwithstanding that, the real-time morphological information attained by OCT scanning, vis-à-vis the 
epidermal and dermal layers in addition to the ability to demonstrate the junction between these two layers, 
makes it a promising mapping instrument. In the most recent pilot study performed by Maier et al. [11], a 
new high-definition optical coherence tomography (HD-OCT) system was used to image 20 biopsies of 
BCC lesions ex vivo in horizontal (en face) and vertical (slice) imaging modes. These OCT images were 
then compared with the gold standard histopathology. The authors reported a higher sensitivity (74%) and 
specificity (64%) compared with a study by Cunha et al., which reported 19% and 56% sensitivity and 
specificity respectively [10]. 
       Although our study shows the advantage of rapid ex vivo OCT scanning of the specimen margin, one 
of the main drawbacks is that we scanned and assessed only four margins (3,6,9, and 12 o’clock positions) 
per specimen. Areas in between the four scanned locations were not imaged. In future studies, this could 
be overcome by scanning the entire margin. Although this would increase scanning time to circa 3-6 
minutes, it still compares favourably with the processing time for Mohs frozen sections.   
5. Conclusion     
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       Our data in this study show the accuracy of the OCT instrument in identifying the margin status of 
BCCs located in the head and neck region, albeit with some false positive and negative margins of the 
excisional biopsies examined. The OCT system demonstrated good correlation with histopathological 
analysis. Furthermore, OCT was successfully employed to differentiate between BCC subtypes. 
Nevertheless, tumour identification was more challenging in thicker tumours exceeding 2mm in depth as 
they extend beyond the OCT signal depth. Eventually, intraoperative OCT imaging may allow a reduction 
in the number of stages of MMS and further optimise preservation of normal tissue.  
       At this moment in time, biopsy and subsequent histopathologic investigation remains the gold 
standard technique in diagnosing skin malignancies. However, refinement of the existing non-invasive 
laser-based modalities, for example CLSM, OCT etc. in terms of resolution and penetration depth may 
improve the early detection of suspicious lesions in the head and neck region and reduce the number of 
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Fig. 1. Diagram shows the direction of OCT scanning (blue arrows) from the periphery towards the centre of the excisional specimen at 
3,6,9 and 12 o’clock positions. 
 
 
Fig. 2. True negative margin from a basal cell carcinoma (BCC) lesion. Both histopathology (H&E) & optical coherence tomography (OCT) 
images (A & B) reveal no tumour cell nests, intact dermo-epidermal junction (DEJ) and homogenous dermis (D). EP= epidermis; HF= hair 
follicle; SeG= sebaceous gland. 
 
Fig. 3. True positive margin from a tumour-laden resection margin of a nodulocystic (or nodular) BCC lesion. Both images (A & B) show 
tumour nests and cystic changes in the papillary & reticular dermis layers (PD & RD), with breach in continuity of DEJ in some areas. The 
convex white line on top of OCT image indicates the glass window of the OCT oral probe.  
 
Fig. 4. OCT oral instrument probe (A) and dermatology probe (B).  
 
Fig. 5. False positive margin of a BCC lesion. H&E image (A) reveals intact DEJ with no tumour nests, whereas OCT image (B) shows no 
clear distinction (DEJ) between epidermal and dermal layers and the presence of numerous large hypo-reflective (low scattering) tumour-
like round structures in both epidermal and dermal layers. 
 
 
Fig. 6. False negative margin of a BCC resection margin. H&E picture (A) showing deep tumour nests of both nodular & micronodular 
subtypes in the reticular dermis, which is clearly beyond OCT penetration depth capability. OCT scan (B) revealing distinct epidermis, 
intact DEJ and homogenous dermis. 
 
 
Fig. 7. Superficial BCC shown in both histology slide & OCT image (A & B). Note the downward growth of basal cell layer of the 
epidermis (arrows) without a breach in the continuity of DEJ. 
 
 
Fig. 8. Mixed nodular & micronodular BCC subtypes shown in both histology slide & OCT image (A & B). Red arrows indicate nodular 
nests, whereas white arrows indicate micronodular basaloid nests. Palisading (halo-like region) is obvious around the ovoid basaloid nest 
(round brackets), which is due to the presence of either mucin secretion within a cleft or nuclear material that has been suggested to cause 
hypo-reflectivity (low scattering properties). The suggested ‘halo’ consists of irreflective circumsriptive thin line.  SwG (sweat glands) can 
be seen in the histopathological image, which is beyond OCT penetration depth ability.  
 
Fig. 9. Infiltrative type BCC shown in both H&E & OCT pictures (A & B). Note the dramatic alteration of the morphology of both 
epidermal and dermal layers in the region where the BCC nests reside in. Variability in shape & size of tumour cell nests is noticeable with 
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Clinical data and BCC histopathology subtypes and location of the cohort investigated (Total 73 subjects). 
 
 Study details                                                                                                                        No (%) 
 
1. Gender                                                                                                                          
        Male                                                                                                                               39 (53.5) 
        Female                                                                                                                           34 (46.5) 
 2. Age                                                                                                                                   67.5 (range 26–96 years)  
 3. Location of BCC 
        Cheek                                                                                                                             17 (23.2) 
        Nose                                                                                                                               17 (23.2) 
        Forehead ⁄temple                                                                                                           14 (19.2) 
        Scalp                                                                                                                              10 (13.7) 
        Periorbital                                                                                                                      10 (13.7) 
        Ear                                                                                                                                    3 (4.2) 
        Lip                                                                                                                                    2 (2.8) 
 4. BCC subtypes 
        Mixed (two or more than two subtypes)                                                                       27 (37) 
        Nodular                                                                                                                          20 (27.4) 
        Micronodular                                                                                                                 11 (15) 
        Infiltrative                                                                                                                        8 (11) 
        Superficial                                                                                                                        7 (9.6)     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
